Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-90
Closed -$1K 1071
2022
Q4
$1K Hold
90
﹤0.01% 1047
2022
Q3
$1K Hold
90
﹤0.01% 1111
2022
Q2
$2K Sell
90
-1,460
-94% -$39.2K ﹤0.01% 1176
2022
Q1
$48K Buy
+1,550
New +$55.7K ﹤0.01% 589
2021
Q4
Sell
-1,550
Closed -$67K 708
2021
Q3
$67K Hold
1,550
﹤0.01% 468
2021
Q2
$71K Hold
1,550
﹤0.01% 454
2021
Q1
$69K Sell
1,550
-50
-3% -$2.1K ﹤0.01% 484
2020
Q4
$63K Buy
1,600
+50
+3% +$1.86K ﹤0.01% 495
2020
Q3
$61K Sell
1,550
-650
-30% -$24.9K ﹤0.01% 465
2020
Q2
$85K Hold
2,200
﹤0.01% 401
2020
Q1
$74K Buy
+2,200
New +$72.2K ﹤0.01% 402
2019
Q3
$75K Hold
2,200
﹤0.01% 433
2019
Q2
$68K Hold
2,200
﹤0.01% 383
2019
Q1
$63K Hold
2,200
﹤0.01% 386
2018
Q4
$63K Hold
2,200
﹤0.01% 373
2018
Q3
$79K Buy
+2,200
New +$93.8K ﹤0.01% 356

Other funds holding NEOG

Bartlett & Co's NEOG Position: Q1 2023 in Review

Bartlett & Co sold out of Neogen (NEOG) in Q1 2023, closing a stake of 90 shares — an estimated $1K sold.

Bartlett & Co first reported a position in NEOG in Q3 2018 and held it in 16 quarters. The position peaked at $85K in Q2 2020. 354 funds tracked by Wall St. Rank hold NEOG as of Q1 2023.

  • Bartlett & Co reported no remaining Neogen position as of Q1 2023 after selling out during the quarter.
  • Bartlett & Co sold 90 Neogen shares in Q1 2023, an estimated $1K.
  • Bartlett & Co first reported a position in Neogen in Q3 2018 and held it in 16 quarters.
  • Bartlett & Co's Neogen position peaked at $85K in Q2 2020.
  • 354 funds tracked by Wall St. Rank held Neogen as of Q1 2023.

Based on Bartlett & Co's 13F filing for Q1 2023, filed 6 Apr 2023.